KAI1 (CD82), specific and highly expressed in PCs rather than ECs, is able to inhibit tumor angiogenesis through promoting the release of leukemia inhibitory factor (LIF) of PCs via Src/P53 pathway. This evidence concerns the gene CD82 and neoplasm.